Rapid and large-scale implementation of HCV treatment advances in France, 2007

Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015

Published:2017-12 Issue:1 Volume:17 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Brouard Cécile^ORCID,Boussac-Zarebska Marjorie,Silvain Christine,Durand Julien,de Lédinghen Victor,Pillonel Josiane,Delarocque-Astagneau Elisabeth

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-017-2889-4.pdf

Reference47 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. The lancet Gastroenterology & hepatology. 2017;2:161–76.

2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.

3. Simmons B, Saleem J, Heath K, Cooke GS, Hill A. Long-term treatment outcomes of patients infected with hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained Virological response. Clin Infect Dis. 2015;61:730–40.

4. Smith-Palmer J, Cerri K, Valentine W. Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits. BMC Infect Dis. 2015;15:19.

5. European Association for the Study of the Liver. EASL recommendations on Treatment of Hepatitis C 2016. J Hepatol. 2017;66:153–94.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Public Policy and COVID-19 Pandemic on Hepatitis C Testing and Treatment in France, 2014–2021;Viruses;2024-05-16

2. Screening for hepatitis C virus at the time of mammography using rapid diagnostic tests in women aged between 50 and 74 years (Mamm'OC NCT05067374);Journal of Viral Hepatitis;2024-05-15

3. Hepatitis C virus cure from direct‐acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort);Drug and Alcohol Review;2023-12-22

4. A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019;Eurosurveillance;2023-02-09

5. Is elimination of HCV realistic by 2030: France;Liver International;2021-06